시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
남성 유방암 치료 시장 규모, 점유율, 성장 분석 : 유형별, 제품 유형별, 치료별, 진단별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Male Breast Cancer Treatment Market Size, Share, Growth Analysis, By Type, By Product Type, By Treatment, By Diagnosis, By End User, By Region - Industry Forecast 2025-2032
상품코드 : 1630636
리서치사 : SkyQuest
발행일 : 2025년 01월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,657,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,957,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,258,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 남성 유방암 치료 시장 규모는 2023년에 44억 달러로 평가되며, 예측 기간(2025-2032년)의 CAGR은 3.7%로, 2024년 45억 6,000만 달러에서 2032년에는 61억 달러로 성장할 전망입니다.

남성 유방암은 드물지만, 특히 인구의 고령화와 비만율 증가로 인해 심각한 문제로 대두되고 있습니다. 이 유형의 암은 유방 조직의 급속한 세포분열로 인해 발생하며, BRCA2와 같은 유전자 변이와 관련이 있는 경우가 많으며, 주로 고령의 남성이 발병하며, 평생 833명 중 1명이 발병할 위험이 있습니다. 흥미롭게도 전체 암의 1%도 되지 않습니다. 그러나 인식의 향상으로 조기 진단과 효과적인 치료 옵션으로 인해 생존율이 개선되고 있습니다. 주요 시장 성장 촉진요인으로는 Bristol-Myers Squibb와 Clovis Oncology의 협력 등에서 알 수 있듯이 암 환자 증가와 바이오테크놀러지의 발전을 들 수 있습니다. 그러나 높은 연구 비용과 일관된 치료 전략의 부재라는 과제도 남아 있으며, 시장 성장에 걸림돌이 될 수 있습니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

남성 유방암 치료 시장 규모 : 유형별

남성 유방암 치료 시장 규모 : 제품 유형별

남성 유방암 치료 시장 규모 : 치료별

남성 유방암 치료 시장 규모 : 진단별

남성 유방암 치료 시장 규모 : 최종사용자별

남성 유방암 치료 시장 규모

경쟁 정보

주요 기업 개요

결론과 권장사항

KSA
영문 목차

영문목차

Global Male Breast Cancer Treatment Market size was valued at USD 4.4 billion in 2023 and is poised to grow from USD 4.56 billion in 2024 to USD 6.1 billion by 2032, growing at a CAGR of 3.7% during the forecast period (2025-2032).

Male breast cancer, although rare, is emerging as a significant concern, particularly as the population ages and obesity rates rise. This cancer type arises from rapid cell division in breast tissue, often linked to genetic mutations such as BRCA2, predominantly affecting older men, with 1 in 833 at risk over their lifetime. Interestingly, it accounts for less than 1% of all cancers. However, increased awareness has improved survival rates through early diagnosis and effective treatment options. Key market drivers include a rise in cancer cases and advancements in biotechnology, as evidenced by collaborations like that of Bristol-Myers Squibb and Clovis Oncology. However, challenges remain, such as the high cost of research and the lack of a cohesive treatment strategy, which may hinder market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Male Breast Cancer Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Male Breast Cancer Treatment Market Segmental Analysis

Global Male Breast Cancer Treatment Market is segmented by Type, Product Type, Treatment, Diagnosis, End User and region. Based on Type, the market is segmented into Ductal Carcinoma in Situ, Paget's Disease of the Nipple, Inflammatory Breast Cancer, Infiltrating Ductal carcinoma and Others. Based on Product Type, the market is segmented into Chemotherapy, Medication and Others. Based on Treatment, the market is segmented into Local Treatments, Radiation Therapy, Targeted Therapy and Systemic Treatments. Based on Diagnosis, the market is segmented into Mammography, Biopsy, Fine Needle Aspiration Biopsy, Core Biopsy, Excisional Biopsy, PET Scan, CT Scan, MRI Scan and Other Tests. Based on End User, the market is segmented into Hospitals, Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Male Breast Cancer Treatment Market

The global market for male breast cancer treatment is significantly driven by rising awareness and enhanced early detection efforts. Initiatives and campaigns aimed at educating the public have played a crucial role in promoting the importance of recognizing the signs of male breast cancer, leading to timely diagnoses. Early detection is fundamental to improving survival rates and treatment success, as it enables healthcare providers to initiate appropriate therapies sooner. Furthermore, advancements in diagnostic technologies and the implementation of comprehensive screening programs have contributed to better patient outcomes, underscoring the critical importance of awareness in combating this rare condition.

Restraints in the Global Male Breast Cancer Treatment Market

The Global Male Breast Cancer Treatment market faces significant restraints due to the limited number of clinical trials and research focused specifically on male patients. This is largely because male breast cancer is rarer than female breast cancer, resulting in insufficient gender-specific research to inform treatment protocols. Consequently, treatment options may be based primarily on data derived from studies primarily involving women, which may not effectively address the unique needs of male patients. This scarcity of targeted research creates challenges in formulating optimal care plans and can potentially compromise the effectiveness of treatments intended for men diagnosed with breast cancer.

Market Trends of the Global Male Breast Cancer Treatment Market

The Global Male Breast Cancer Treatment market is experiencing a significant transformation driven by rising awareness and the evolving oncology landscape. Historically overshadowed by female breast cancer, the increasing recognition of male breast cancer has prompted dedicated research and development initiatives. Notably, a surge in male breast cancer cases has catalyzed the medical community to allocate resources towards specialized treatments and innovative therapies. This paradigm shift is fostering collaboration among researchers, clinicians, and advocates, culminating in enhanced early detection, personalized treatment options, and improved outcomes for affected men. The market is poised for growth as it increasingly focuses on addressing this unique patient demographic.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Male Breast Cancer Treatment Market Size by Type & CAGR (2025-2032)

Global Male Breast Cancer Treatment Market Size by Product Type & CAGR (2025-2032)

Global Male Breast Cancer Treatment Market Size by Treatment & CAGR (2025-2032)

Global Male Breast Cancer Treatment Market Size by Diagnosis & CAGR (2025-2032)

Global Male Breast Cancer Treatment Market Size by End User & CAGR (2025-2032)

Global Male Breast Cancer Treatment Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기